J.Molner AS (OTSE:MOLNR) Short-Term Debt : €0.27 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Short-Term Debt?

J.Molner AS's Short-Term Debt for the quarter that ended in Dec. 2023 was €0.27 Mil.

J.Molner AS's quarterly Short-Term Debt increased from Dec. 2022 (€0.27 Mil) to Jun. 2023 (€0.28 Mil) but then declined from Jun. 2023 (€0.28 Mil) to Dec. 2023 (€0.27 Mil).

J.Molner AS's annual Short-Term Debt increased from Dec. 2021 (€0.25 Mil) to Dec. 2022 (€0.27 Mil) but then declined from Dec. 2022 (€0.27 Mil) to Dec. 2023 (€0.27 Mil).

J.Molner AS Short-Term Debt Historical Data

The historical data trend for J.Molner AS's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Short-Term Debt Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Debt

0.25

0.27

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	0.25	0.27	0.27	0.28	0.27

J.Molner AS Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

J.Molner AS Short-Term Debt Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines